REACH compliance management

Under the REACH Regulation, the industry has a responsibility to identify and manage the risks associated with the chemicals they manufacture and market in the EU. 


Manufacturers and importers of substances in quantities of 1 tonne or more per year need to gather information on substance properties and uses, make an assessment of hazards and potential risks and submit a registration dossier to the European Chemicals Agency (ECHA) demonstrating that any risks are adequately controlled.  Failure to register within the required timescales means that the substance will no longer be allowed to be manufactured or imported until compliance is achieved.

From May 2018, phase-in substances manufactured or imported in the EU in quantities of 1-100 tonnes or more per year must be registered.  REACH places a significant burden on industry and presents numerous challenges, particularly to small and medium-sized enterprises (SMEs) that may not have the resources available to meet registration requirements.

We can help you achieve REACH compliance and ensure the continued success of your products by providing tailored and cost-effective support and advice. 

Our range of services includes:

  • Scoping of regulatory obligations under REACH;
  • Substance identification and characterisation;
  • Preparation of an Inquiry Dossier to enable data sharing;
  • Collation and review of existing information on substance properties and identification of data gaps;
  • Preparation of a registration dossier in IUCLID and pre-submission screening;
  • Development of testing proposals;
  • Preparation of a Chemical Safety Report using CHESAR;
  • Establishing Derived No Effect Levels (DNELs) and Risk Characterisation Ratios (RCRs) for human exposures;
  • Identification of exposure scenarios and exposure assessment based on existing data and modelling with additional measurements;
  • Support for gathering information on uses from downstream users;
  • Provision of guidance and training on REACH processes and related topics.
We're here to provide you with more information and answer any questions you may have. Contact us
  • IOMworld Posted: 7 days ago
    Read the independent report on #COVID and Occupational Impacts from the UK Injuries Advisory Council. IOM's John Ch… https://t.co/ibKrBhgyul
  • IOMworld Posted: 12 days ago
    RT @therealfclabs: A week today! Free webinar - panel discussion and audience questions. Be part of the conversation. https://t.co/X59e9
  • IOMworld Posted: 13 days ago
    Improving understanding of gloves & dermal exposure to chemicals for professionals everywhere, IOM’s Karen Galea &… https://t.co/Tt4NUoa6y3
  • IOMworld Posted: 14 days ago
    RT @EU_OSHA: Systematic, holistic approach to #riskAssessment, covering both physical and psychosocial risks. This should actively involve…
  • IOMworld Posted: 15 days ago
    Sharing our knowledge on Respirable Crystalline Silica, check out our advice and expertise in a recent published ar… https://t.co/zmBZVu5FC2
  • IOMworld Posted: 20 days ago
    As Airmon 2022 has now come to an end, we wish to thank everyone for visiting our stand. We have enjoyed meeting &… https://t.co/afjwvLYDYj
  • IOMworld Posted: 21 days ago
    IOM's research has helped to better understand stress and psychosocial issues and how to manage these for safer and… https://t.co/xI9q77HLE3
  • IOMworld Posted: 22 days ago
    IOM improving ventilation for a healthier world. To protect patients, staff & limit the spread of COVID-19, find ou… https://t.co/UUUe7OgsAm
  • IOMworld Posted: 22 days ago
    Today! Join the Low Cost Particulate Matter Sensors in the Workplace workshop at 16:00. This workshop will aim to g… https://t.co/cTAPo2692e
  • IOMworld Posted: 23 days ago
    The Airmon 10 event is now underway. Come & visit our stand where our experts will be delighted to answer your ques… https://t.co/BKgJPDGMvQ